Vol 6, Supplement 1 (July 20, 2017): Chinese Clinical Oncology (Contemporary and Future Treatment for Meningioma-Guest Editors: Matthias Preusser, Priscilla Brastianos, Helen A Shih)

Editorial

Meningioma research—status quo and quo vadis
Matthias Preusser, Priscilla Brastianos, Helen A Shih
Chinese Clinical Oncology  
2017;
6
(Suppl 1)
:S1
.

Review Article

Classification of meningiomas—advances and controversies
Patrick N. Harter, Yannick Braun, Karl H. Plate
Chinese Clinical Oncology  
2017;
6
(Suppl 1)
:S2
.
Radiation for skull base meningiomas: review of the literature on the approach to radiotherapy
Fabio Y. Moraes, Caroline Chung
Chinese Clinical Oncology  
2017;
6
(Suppl 1)
:S3
.
Radiation therapy for WHO grade I meningioma
Samuel E. Day, Lia M. Halasz
Chinese Clinical Oncology  
2017;
6
(Suppl 1)
:S4
.
The role of radiotherapy in the management of high-grade meningiomas
Katie L. Hwang, William L. Hwang, Marc R. Bussière, Helen A. Shih
Chinese Clinical Oncology  
2017;
6
(Suppl 1)
:S5
.
Animal models of meningiomas
Christian Mawrin
Chinese Clinical Oncology  
2017;
6
(Suppl 1)
:S6
.

Perspective

Current and emerging principles in surgery for meningioma
Wenya Linda Bi, Ian F. Dunn
Chinese Clinical Oncology  
2017;
6
(Suppl 1)
:S7
.

Disclosure:

The supplement “Contemporary and Future Treatment for Meningioma” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Matthias Preusser, Priscilla Brastianos and Helen A Shih served as the unpaid Guest Editors for the supplement.